YOLFTbeta
Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc

CNSL · LSE · Healthcare / Medical Instruments & Supplies

1.45GBX+0.05 (+3.57%)

Price History

Full chart

Market Stats

Previous Close1.40
Open1.40
Day Range1.38 – 1.60
52-Week Range1.26 – 3.00
Volume7.83K
Market Cap3.69M
P/E (TTM)0.00
Forward P/E99.01
EPS-0.02
Dividend Yield0.00%
Beta1.91
50-Day Avg1.70
200-Day Avg1.87

About

Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, the Americas, India, rest of Asia and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the public, clinics, and health professionals; and supplies Food Detective, a food sensitivity test. In addition, the company offers Gut Detective, a comprehensive stool biomarker panel used to investigate key areas of gut health, including inflammation, digestive enzyme production and intestinal permeability; and CNS Lab, which provides laboratory services for food sensitivity. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc is based in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. James Cooper B.A., M.Sc.
  • Employees85
  • HeadquartersOne Fleet Place, London, United Kingdom, EC4M 7WS, UK
  • Websitehttps://www.cnsplc.com

Leadership

  • Mr. James Cooper B.A., M.Sc.CEO & Executive Director · b. 1991
  • Mr. Ajay Patel A.C.A., L.L.B.CFO, Secretary & Executive Director · b. 1964
  • Mr. Iain Alexander James LoganGroup Financial Controller · b. 1973
  • Mr. Prashant ManiarManaging Director of Omega Dx Asia Pvt Limited
  • Motunrayo OyegunleSecretary
  • Mr. Andrew William Shepherd BSc.(Hons)Global Ambassador - Life President · b. 1956

Financials

Income Statement

Currency: GBP2004-12-312005-03-312005-12-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue-----3.49M5.44M6.20M7.90M11.12M11.26M11.59M12.11M12.74M14.25M8.33M8.76M9.82M6.82M8.54M7.55M9.77M8.33M6.97M
Growth (%)------+55.73%+13.99%+27.47%+40.78%+1.25%+2.94%+4.41%+5.28%+11.79%-41.53%+5.13%+12.13%-30.58%+25.28%-11.63%+29.53%-14.77%-16.27%
Cost of Revenue-----1.59M2.09M2.58M3.20M4.12M4.21M4.22M4.43M4.61M5.03M2.85M3.12M3.52M2.82M3.79M4.37M3.73M3.33M2.70M
Gross Profit-----1.90M3.34M3.62M4.71M7.00M7.05M7.37M7.67M8.14M9.22M5.48M5.63M6.29M4.00M4.75M3.17M6.05M5.00M4.28M
Gross Margin-----54.35%61.49%58.34%59.55%62.96%62.62%63.58%63.39%63.84%64.73%65.78%64.32%64.10%58.63%55.62%42.05%61.86%60.08%61.32%
Operating Expense-----1.60M2.77M3.31M4.57M6.49M6.75M6.84M7.00M7.47M8.53M6.92M5.90M14.34M4.48M5.33M5.95M6.58M5.64M5.32M
Operating Income-79.00K-79.00K-92.00K-92.00K-298.00K573.00K307.00K136.00K517.11K306.64K527.33K672.97K669.76K694.76K-1.44M-271.34K-8.05M-488.00K-582.00K-2.78M-535.00K-640.00K-1.04M
Operating Margin-----8.53%10.54%4.95%1.72%4.65%2.72%4.55%5.56%5.26%4.88%-17.31%-3.10%-81.94%-7.16%-6.82%-36.83%-5.47%-7.68%-14.98%
EBITDA-79.00K-79.00K-92.00K-92.00K16.11K352.00K558.51K469.20K474.00K1.21M983.92K1.25M1.42M1.32M1.29M-816.24K201.86K-6.89M418.00K-382.00K-2.65M-73.00K2.20M-392.00K
EBITDA Margin-----10.08%10.27%7.57%6.00%10.88%8.74%10.80%11.72%10.34%9.08%-9.80%2.31%-70.21%6.13%-4.47%-35.09%-0.75%26.39%-5.62%
Net Income-73.00K-73.00K-85.00K-85.00K-238.00K221.00K187.00K31.00K526.98K582.27K692.85K739.05K571.91K713.26K-7.27M974.25K-6.83M-2.10M-11.33M-3.86M-328.00K1.57M-5.83M
Net Income Margin-----6.82%4.06%3.02%0.39%4.74%5.17%5.98%6.11%4.49%5.01%-87.28%11.13%-69.54%-30.87%-132.72%-51.15%-3.36%18.80%-83.53%
R&D-----137.00K226.00K209.75K250.00K487.00K140.81K245.87K307.15K258.31K199.91K145.46K23.62K37.63K133.00K343.00K274.00K343.00K433.00K134.00K
R&D as % of Total Revenue-----3.92%4.16%3.38%3.16%4.38%1.25%2.12%2.54%2.03%1.40%1.75%0.27%0.38%1.95%4.02%3.63%3.51%5.20%1.92%
Interest Expense-----187.42K107.00K47.00K32.00K50.95K32.44K28.98K30.62K24.15K39.98K36.35K97.08K251.81K78.00K21.00K13.00K22.00K17.00K13.00K
Interest Expense % of Total Revenue-----5.37%1.97%0.76%0.40%0.46%0.29%0.25%0.25%0.19%0.28%0.44%1.11%2.56%1.14%0.25%0.17%0.23%0.20%0.19%

Balance Sheet

Currency: GBP2004-12-312005-03-312005-12-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets223.00K-152.00K-1.75M8.06M8.26M9.15M17.40M16.71M17.61M21.99M22.64M23.78M25.76M22.90M23.48M18.84M29.55M17.84M14.40M13.89M13.80M7.45M
Total Liabilities16.00K-30.00K-1.70M4.60M3.90M3.50M4.44M3.39M3.65M3.53M3.83M3.59M4.30M5.78M5.28M5.23M6.16M6.02M4.45M4.21M2.39M1.77M
Total Equity207.00K-122.00K-51.24K3.46M4.37M5.65M12.96M13.32M13.96M18.46M18.81M20.19M21.46M17.12M18.19M13.61M23.38M11.82M9.95M9.68M11.41M5.68M
Cash223.00K-152.00K-634.65K513.00K613.00K678.00K2.05M1.16M160.69K3.12M1.97M1.30M737.33K115.72K--5.83M1.60M5.12M2.94M4.87M2.64M
Total Debt----317.08K2.27M2.25M1.94M1.61M1.30M844.47K746.87K553.22K821.39K862.77K882.88K921.76K2.57M452.00K370.00K74.00K148.00K349.00K125.00K
Net Debt-223.00K--152.00K--317.57K1.75M1.64M1.26M-446.00K145.07K683.78K-2.37M-1.42M-480.86K125.44K767.16K921.76K2.57M-5.38M-1.24M-5.04M-2.79M-4.52M-2.51M

Cash Flow

Currency: GBP2004-12-312005-03-312005-12-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow-57.00K-57.00K-71.00K-71.00K14.75K312.00K600.00K170.00K322.00K685.98K1.01M1.67M1.25M1.45M2.01M-828.50K368.82K547.61K-2.42M-3.23M-3.15M607.00K83.00K-1.13M
Investing Cash Flow---12.39K-12.39K-10.70K-3.03M-185.00K-668.00K-5.67M-1.20M-1.49M-2.28M-2.05M-2.02M-2.66M-3.28M-894.47K-2.15M-2.83M-493.00K5.18M-2.51M2.12M-810.00K
Financing Cash Flow280.00K280.00K-60.05K-60.05K671.63K2.86M-315.00K564.00K6.71M-345.43K-522.24K3.62M-224.27K-166.68K-19.30K3.48M534.97K1.64M11.07M-502.00K1.49M-265.00K-251.00K-232.00K
Capital Expenditure000032.47K158.00K27.00K90.00K764.00K1.22M1.49M2.36M2.10M2.04M2.66M3.28M2.69M2.15M2.83M1.48M153.00K59.00K225.00K253.00K
Free Cash Flow-57.00K-57.00K-71.00K-71.00K-17.72K154.00K573.00K80.00K-442.00K-537.16K-479.06K-690.71K-847.82K-585.51K-649.01K-4.11M-2.33M-1.61M-5.24M-4.71M-3.31M548.00K-142.00K-1.39M
FCF to OCF100.00%100.00%100.00%100.00%-120.16%49.36%95.50%47.06%-137.27%-78.31%-47.20%-41.38%-67.94%-40.28%-32.27%495.78%-630.57%-293.32%216.78%145.77%104.85%90.28%-171.09%122.31%

Earnings

Report DateNov 30, 2015Aug 1, 2016Nov 21, 2016Jul 17, 2017Dec 14, 2017Aug 6, 2018Dec 3, 2018Sep 23, 2019Dec 2, 2019Jul 14, 2020Nov 30, 2020Jul 13, 2021Nov 25, 2021Jul 11, 2022Nov 23, 2022Nov 21, 2024Aug 19, 2025Nov 10, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.00
EPS Actual0.000.000.000.000.00-0.060.01-0.010.00-0.040.00-0.01-0.020.010.000.00-0.000.00
Surprise----------------70.00%-
Timing------------------

Key Statistics & Ratios

Market Cap3.69M
Enterprise Value1.06M
Trailing P/E0.00
Forward P/E99.01
Price / Sales0.53
Price / Book0.63
EPS-0.02
Book Value0.024
Revenue (TTM)6.97M
Gross Profit (TTM)4.73M
EBITDA-989.00K
Profit Margin-83.53%
Operating Margin-29.34%
Return on Equity-68.18%
Return on Assets-7.20%
Shares Outstanding237.95M
Shares Float187.43M
Beta1.91
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 31, 20071:40